Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?

Neurology

Volumn 77, Issue 9, 2011, Pages 812-813

  Weinshenker, Brian G ^a   Carroll, William M ^b  

^a MAYO CLINIC   (United States)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT; OLIGOCLONAL BAND; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AQP4 PROTEIN, HUMAN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ASIA; BRAIN DISEASE; DIAGNOSTIC ERROR; EDITORIAL; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINALLY EXTENSIVE SPINAL CORD LESION; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPINAL CORD LESION; ASIAN; BIOSYNTHESIS; FEMALE; IMMUNOLOGY; MALE; NOTE;

AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; FEMALE; HUMANS; MALE; NEUROMYELITIS OPTICA;

EID: 80055099182     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31822b012a     Document Type: Editorial

References (10)

1. Siritho S, Nakashima I, Takahashi T, Fujihara K, Prayoonwiwat N. AQP4 antibody-positive Thai cases: clinical features and diagnostic problems. Neurology 2011; 77:827-834.
2. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489. (Pubitemid 43958540)
3. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6: 805-815. (Pubitemid 47238676)
4. Takahashi T, Miyazawa I, Misu T, et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry, 2008;79:1075-1078.
5. Nakamura M, Misu T, Fujihara K, et al. Occurrence of acute large and edematous callosal lesions in neuromyelitisoptica. Mult Scler 2009;15:695-700.
6. Magana SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009;72:712-717.
7. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese [see comment]. Brain 2007;130:1206-1223. (Pubitemid 47355945)
8. Osuntokun BO. The pattern of neurological illness in tropical Africa: experience at Ibadan, Nigeria. J Neurol Sci, 1971;12:417-442.
9. Chang KH, Lyu RK, Chen CM, et al. Clinical characteristicsof multiple sclerosis in Taiwan: a cross-sectional study. Mult Scler 2006;12:501-506.
10. Bizzoco E, Lolli F, Repice AM, et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 2009;256:1891-1898.